memantine, Namenda, Namenda XR (cont.)
Omudhome Ogbru, PharmD
Omudhome Ogbru, PharmD
Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.
Medical and Pharmacy Editor:
PRESCRIBED FOR: Memantine is used for the treatment of moderate to severe dementia associated with Alzheimer's. Dementia can be categorized into three levels of severity: mild in which patients are alert and sociable, but forgetfulness begins to interfere with daily living, moderate which often is the longest stage of the disease with deterioration of intellect, logic, behavior, and function, and severe, in which there is loss of long-term memory and language skills. Patients with severe Alzheimer's may require 24-hour care and can no longer complete basic self-care tasks including washing, eating, and using the bathroom.
SIDE EFFECTS: The most common side effects of memantine are:
Memantine may cause a serious skin reaction called Stevens-Johnson syndrome.
GENERIC AVAILABLE: Yes.
PREPARATIONS: Tablets: 5 and 10 mg. Capsule (extended release): 7, 14, 21 and 28 mg. Solution: 2 mg/ml.
STORAGE: Tablets should be stored at room temperature, 15 C - 30 C (59 F - 86 F).
DOSING: The usual starting dose of memantine tablets is 5 mg once daily. The dose usually is increased to 5 mg twice daily, then 5 mg and 10 mg as separate doses daily, and finally 10 mg twice daily. Memantine can be taken with or without food. The initial recommended dose of memantine capsules is 7 mg daily. The dose may be increased weekly by 7 mg daily and the maximum dose is 28 mg daily. Capsules may be swallowed whole or opened and sprinkled on spoonsful of applesauce. Capsules should not be crushed or chewed.
DRUG INTERACTIONS: Medicines that make the urine more alkaline (for example, carbonic anhydrase inhibitors such as acetazolamide (Diamox) and sodium bicarbonate would be expected to reduce the elimination of memantine by the kidneys and might increase the blood levels and the risk of side effects of memantine. Combining memantine with other NMDA receptor antagonists (for example, amantadine [Symmetrel], ketamine, and dextromethorphan) has not been evaluated and should be done cautiously.
Medically Reviewed by a Doctor on 2/24/2015
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Back to Medications Index